Spain Bariatric Surgery Devices Market Analysis

Spain Bariatric Surgery Devices Market Executive Summary

The Spain Bariatric Surgery Devices Market is at around $51.3 Mn in 2023 and is projected to reach $68.5 Mn in 2030, exhibiting a CAGR of 4.2% during the forecast period 2023-2030.

Weight-loss surgery, also called metabolic and bariatric surgery, is an operation that makes changes to the digestive system. It is intended for people who have obesity and need to lose weight but have not been able to do so through other means. While bariatric surgery can offer many benefits, all forms of weight-loss surgery are major procedures that can pose risks and side effects. Also, you must make permanent healthy changes to your diet and get regular exercise to help ensure the long-term success of bariatric surgery. Bariatric surgery is done to help you lose extra weight and reduce your risk of possibly life-threatening weight-related health problems, including: certain cancers, including breast, endometrial and prostate cancer, heart disease and stroke, high blood pressure, high cholesterol levels, Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), sleep apnoea, type 2 diabetes etc.

According to World Obesity Federation report 2022, Spain is living with overweight or obesity around 23.3% overweight and 17.3% obese. The prevalence of obesity is more in males then female, around 16.5% males and 15% females are obese in Spain. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Anaconda Biomed, Stryker, Medtronic, B. Braun, Johnson & Johnson, Cousin Surgery among others.

Market Dynamics

Market Drivers

Government Initiatives to Curb Obesity: The Spanish government has launched initiatives like the NAOS (Nutrition, Physical Activity and Prevention of Obesity) Strategy to raise awareness about obesity and promote healthy lifestyle habits. Programs like the "childhood obesity" initiative by the Gasol Foundation and the HAPPI (Healthy Active Preschool Parents Initiative) project are also aimed at preventing obesity, which can drive the demand for bariatric surgeries and associated devices.

Technological Advancements in Bariatric Surgery Devices: Companies are investing in R&D to develop new and improved bariatric surgery devices, such as minimally invasive techniques and closure devices. These technological advancements are driving the adoption of bariatric surgery devices in Spain.

Rising obesity rates in Spain: Spain has been experiencing a steady increase in obesity rates over the past few decades. According to World Obesity Federation report 2022, Spain is living with overweight or obesity around 23.3% overweight and 17.3% obese. The prevalence of obesity is more in males then female, around 16.5% males and 15% females are obese in Spain. This trend is creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Market Restraints

Exorbitant expenses linked to bariatric procedures and equipment: The high cost of bariatric surgery procedures in Spain can make them inaccessible to many patients, limiting the adoption of these devices. Thus, hampering its growth in Spain.

Lack of Trained Professionals: The limited availability of healthcare professionals trained in performing bariatric surgeries and managing post-operative care, hinders the growth of the market.

Poor Healthcare Infrastructure and Lack of Reimbursement: Inadequate healthcare infrastructure in some regions of Spain limit the availability and quality of bariatric surgery services. The lack of reimbursement policies for these procedures also make them unaffordable for many patients. Thus, hampering the market growth rate.

Regulatory Landscape and Reimbursement Scenario

The Spanish Agency of Medicines and Medical Devices (AEMPS) is the primary body responsible for regulating medical devices, including those used in bariatric surgery. The Ministry of Health, Consumer Affairs and Social Welfare oversees general healthcare policies and coordinates with regional health authorities. The Interterritorial Council of the National Health System (CISNS) plays a crucial role in harmonizing health policies across Spain's autonomous communities.

Spanish Network of Health Technology Assessment Agencies (REDETS) conducts health technology assessments, while the Commission for Benefits, Insurance and Financing (CBAF) advises on including new treatments in the national health system's portfolio. The National Health System's Quality Agency evaluates healthcare quality and safety. Regional health services have significant autonomy in implementing national policies and may have additional requirements or variations in coverage for bariatric procedures. The General Council of Official Colleges of Physicians (CGCOM) provides ethical guidelines and professional standards. These bodies collectively influence the approval, access, and reimbursement of bariatric surgery devices within Spain's decentralized healthcare system.

Competitive Landscape

Key Players

Here are some of the major key players in the Spain Bariatric Surgery Devices Market:

• Anaconda Biomed
• Stryker
• Medtronic plc.
• Apollo Endosurgery
• Ethicon, Inc. (Johnson & Johnson)
• B Braun Melsungen AG
• Cousin Surgery
• Olympus Corporation
• SPATZ FIGA, Inc.
• Teleflex Incorporated
• USGI Medical, Inc.